MAIA Biotechnology, Inc.
  • About
    • About Us
    • Management
    • Board of Directors
    • Advisors
    • Careers
  • Programs
    • Pipeline
    • THIO Program
    • Second-Generation Programs
    • Publications
  • Partners
  • Investors
  • Contact
  • Menu Menu
  • Twitter
  • LinkedIn

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Analyst Coverage
    • Presentations
    • Contacts
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 27, 2022 7:52pm EDT

MAIA Biotechnology Announces Pricing of Initial Public Offering

Jul 18, 2022 8:00am EDT

MAIA Biotechnology Doses First Patient With THIO in Phase 2 Trial (THIO-101) for Non-Small Cell Lung Cancer

Jun 14, 2022 8:14am EDT

MAIA Biotechnology, Inc. Announces Research Collaboration with Nationwide Children’s Hospital to Evaluate THIO in Combination with Standard-of-Care Cancer Therapies

May 19, 2022 8:45am EDT

MAIA Biotechnology, Inc. Establishes Wholly Owned Subsidiaries in Romania and Australia to Support Global Development of THIO

Apr 26, 2022 8:37am EDT

MAIA Biotechnology, Inc. Announces FDA Orphan Drug Designation for THIO for the Treatment of Hepatocellular Carcinoma (HCC)

Mar 16, 2022 8:07am EDT

MAIA Biotechnology, Inc. Announces $2.4 Million Financing to Advance Targeted Immuno-Oncology Studies

Mar 15, 2022 8:00am EDT

MAIA Biotechnology, Inc. Announces HREC Approval in Australia for its THIO-101 Phase 2 Trial for NSCLC

Nov 09, 2021 8:04am EST

MAIA Biotechnology, Inc. Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC)

Sep 28, 2021 8:00am EDT

MAIA Biotechnology, Inc. Announces the Appointment of Steven M. Chaouki to Its Board of Directors

Sep 15, 2021 8:08am EDT

MAIA Biotechnology, Inc. Announces Formation of Scientific Advisory Board

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© Copyright 2023 - MAIA Biotechnology, Inc.     312.416.8592     |     info@maiabiotech.com     |     Terms of Use    |     Privacy Policy    |     Cookies Policy